Get started
Author

Panagiotis Zikos

VAD-doxil versus VAD-doxil plus thalidomide as initial treatment for multiple myeloma: results of a multicenter randomized trial of the Greek myeloma study group
2007 · K Zervas, D Mihou, et al. · Annals of Oncology · 69
PDF
The Assessment of the Hematopoietic Reservoir After Immunosuppressive Therapy or Bone Marrow Transplantation in Severe Aplastic Anemia
1998 · Marina Podestà, Giovanna Piaggio, et al. · Blood · 63
Markers of Endothelial and In Vivo Platelet Activation in Patients with Essential Thrombocythemia and Polycythemia Vera
2004 · Marina Karakantza, Nikolaos C. Giannakoulas, et al. · International Journal of Hematology · 45
“Real-world” data on the efficacy and safety of lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma who were treated according to the standard clinical practice: a study of the Greek Myeloma Study Group
2013 · Eirini Katodritou, Chrysanthi Vadikolia, et al. · Annals of Hematology · 42
The incidence of myelodysplastic syndromes in Western Greece is increasing
2013 · Christina Avgerinou, Yannis Alamanos, et al. · Annals of Hematology · 35
PDF
Allogeneic bone marrow or peripheral blood cell transplants in adults with hematologic malignancies: a single-center experience.
1998 · A Bacigalupo, P Zikos, et al. · PubMed · 35
Occupational, dietary, and other risk factors for myelodysplastic syndromes in Western Greece
2017 · Christina Avgerinou, Ioanna Giannezi, et al. · Hematology · 30
PDF
Real-world data on Len/Dex combination at second-line therapy of multiple myeloma: treatment at biochemical relapse is a significant prognostic factor for progression-free survival
2018 · Eirini Katodritou, Marie-Christine Kyrtsonis, et al. · Annals of Hematology · 21
PDF
Addition of cyclosporin-A to chemotherapy in secondary (post-MDS) AML in the elderly. A multicenter randomized trial of the Leukemia Working Group of the Hellenic Society of Hematology
2006 · P. Matsouka, M. Pagoni, et al. · Annals of Hematology · 20
Real‐world data on incidence, clinical characteristics and outcome of patients with macrofocal multiple myeloma (MFMM) in the era of novel therapies: A study of the Greco‐Israeli collaborative myeloma working group
2020 · Eirini Katodritou, Efstathios Kastritis, et al. · American Journal of Hematology · 18
PDF
Serum ferritin and ECOG performance status predict the response and improve the prognostic value of IPSS or IPSS-R in patients with high-risk myelodysplastic syndromes and oligoblastic acute myeloid leukemia treated with 5-azacytidine: a retrospective analysis of the Hellenic national registry of myelodysplastic and hypoplastic syndromes
2020 · Sotirios G. Papageorgiou, Ioannis Kotsianidis, et al. · Therapeutic Advances in Hematology · 18
PDF
The outcome of patients with high‐risk MDS achieving stable disease after treatment with 5‐azacytidine: A retrospective analysis of the Hellenic (Greek) MDS Study Group
2018 · Sotirios G. Papageorgiou, Christos K. Kontos, et al. · Hematological Oncology · 15
The prognostic value of monosomal karyotype (MK) in higher‐risk patients with myelodysplastic syndromes treated with 5‐Azacitidine: A retrospective analysis of the Hellenic (Greek) Myelodysplastic syndromes Study Group
2018 · Sotirios G. Papageorgiou, Diamantina Vasilatou, et al. · American Journal of Hematology · 10
PDF
Real‐life experience of luspatercept in transfusion‐dependent lower risk myelodysplastic syndrome patients
2025 · Anthi Bouchla, Sotirios G. Papageorgiou, et al. · British Journal of Haematology · 9
PDF
VAD-doxil vs.VAD-doxil Plus Thalidomide as Initial Treatment in Patients with Multiple Myeloma: A Multicenter Randomized Trial of the Greek Myeloma Study Group.
2006 · Konstantinos Zervas, Dimitra Mihou, et al. · Blood · 9
Expression of Granzyme B and Perforin in Multiple Myeloma
2001 · Iordanis Xagoraris, George Paterakis, et al. · Acta Haematologica · 9
The effect of 5‐azacytidine treatment delays and dose reductions on the prognosis of patients with myelodysplastic syndrome: how to optimize treatment results and outcomes
2020 · Panagiotis T. Diamantopoulos, Argiris Symeonidis, et al. · British Journal of Haematology · 7
PDF
The prognostic significance of chromosome 17 abnormalities in patients with myelodysplastic syndrome treated with 5‐azacytidine: Results from the Hellenic 5‐azacytidine registry
2019 · Panagiotis Diamantopoulos, Dafni Koumbi, et al. · Cancer Medicine · 7
PDF
Myelodysplastic neoplasm with isolated thrombocytopenia and immune thrombocytopenic purpura in adults: insights from a comparison of two national registries
2023 · Konstantinos Liapis, Vasileios Papadopoulos, et al. · Leukemia · 6
Characteristics of Long-Term Survival in Patients With Myelodysplastic Syndrome Treated With 5-Azacyditine: Results From the Hellenic 5-Azacytidine Registry
2019 · Panagiotis T. Diamantopoulos, Vasiliki Pappa, et al. · Clinical Lymphoma Myeloma & Leukemia · 6
A retrospective study of azacitidine treatment in patients with intermediate-2 or high risk myelodysplastic syndromes in a real-world clinical setting in Greece
2016 · Vasiliki Pappa, Achilles Anagnostopoulos, et al. · International Journal of Hematology · 6
Evaluation of a Bone Marrow Dysmyelopoiesis Immunophenotypic Index for the Diagnosis and Prognosis of Myelodysplastic Syndromes
2015 · Evgenia Verigou, Polixeni Lampropoulou, et al. · Cardiovascular & Haematological Disorders - Drug Targets · 6
Lenalidomide Efficacy in Patients with MDS and Del-5q: Real-World Data from the Hellenic (Greek) National Myelodysplastic & Hypoplastic Syndromes Registry (EAKMYS)
2025 · Argiris Symeonidis, Panagiotis Diamantopoulos, et al. · Cancers · 5
Pomalidomide Plus Low-Dose Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients: Results of the Real-World “POWERFUL” Study
2021 · Evangelos Terpos, Panagiotis Repousis, et al. · Journal of Clinical Medicine · 5
PDF
Effectiveness of 5-Azacytidine in older patients with high-risk myelodysplastic syndromes and oligoblastic acute myeloid leukemia: A retrospective analysis of the Hellenic (Greek) MDS Study Group
2019 · Sotirios G. Papageorgiou, Christos K. Kontos, et al. · Journal of Geriatric Oncology · 5
PDF
Works count: 79
Citation count: 550
H-index: 12
I10-index: 13
Year
Topic
Type